Complement System Activation by Amyloid Aggregates of Aβ(1-40) and Aβ(1-42) Peptides: Facts and Hypotheses

被引:3
|
作者
Yakupova E.I. [1 ]
Bobyleva L.G. [1 ]
Vikhlyantsev I.M. [1 ,2 ]
Bobylev A.G. [1 ,2 ]
机构
[1] Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, ul. Institutskaya 3, Pushchino, 142290, Moscow oblast
[2] Pushchino State Institute of Natural Sciences, pr. Nauki 3, Pushchino, 142290, Moscow oblast
基金
俄罗斯基础研究基金会;
关键词
Alzheimer’s disease; amyloidoses; amyloids; Keywords: complement system;
D O I
10.1134/S000635092001025X
中图分类号
学科分类号
摘要
Abstract—Here, we consider the problem of the activation of the complement system by amyloid aggregates, in particular, amyloid fibrils of the Aβ(1-40) and Aβ(1-42) peptides found in the brain of patients with Alzheimer’s disease. In 1992, based on the data on colocalization of amyloid inclusions with complement system proteins in the brains of patients with this disease, it was suggested that this system is directly activated by amyloids. This hypothesis has been supported by a number of subsequent publications. However, in this study, we did not find evidence to support this idea. The issue remains as to whether amyloids activate the complement system, and, if not, which mechanism is responsible for its activation. Here, we try to elucidate these issues. © 2020, Pleiades Publishing, Inc.
引用
收藏
页码:18 / 21
页数:3
相关论文
共 50 条
  • [31] An automated clinical mass spectrometric method for identification and quantification of variant and wild-type amyloid-β 1-40 and 1-42 peptides in CSF
    DeMarco, Mari L.
    Quyen Nguyen
    Fok, Alice
    Hsiung, Ging-Yuek Robin
    van der Gugten, J. Grace
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2020, 12 (01)
  • [32] Is plasma amyloid-β 1-42/1-40 a better biomarker for Alzheimer's disease than AβX-42/X-40?
    Klafki, Hans-Wolfgang
    Morgado, Barbara
    Wirths, Oliver
    Jahn, Olaf
    Bauer, Chris
    Esselmann, Hermann
    Schuchhardt, Johannes
    Wiltfang, Jens
    FLUIDS AND BARRIERS OF THE CNS, 2022, 19 (01)
  • [33] Enhanced Aβ1-40 Production in Endothelial Cells Stimulated with Fibrillar Aβ1-42
    Rajadas, Jayakumar
    Sun, Wenchao
    Li, Hai
    Inayathullah, Mohammed
    Cereghetti, Damiano
    Tan, Aaron
    Coelho, Valeria de Mello
    Chrest, Francis J.
    Kusiak, John W.
    Smith, Wanli Wei
    Taub, Dennis
    Wu, Joseph C.
    Rifkind, Joseph M.
    PLOS ONE, 2013, 8 (03):
  • [34] Combination of plasma amyloid beta(1-42/1-40)and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
    Verberk, Inge M. W.
    Thijssen, Elisabeth
    Koelewijn, Jannet
    Mauroo, Kimberley
    Vanbrabant, Jeroen
    de Wilde, Arno
    Zwan, Marissa D.
    Verfaillie, Sander C. J.
    Ossenkoppele, Rik
    Barkhof, Frederik
    van Berckel, Bart N. M.
    Scheltens, Philip
    van der Flier, Wiesje M.
    Stoops, Erik
    Vanderstichele, Hugo M.
    Teunissen, Charlotte E.
    ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
  • [35] The Recombinant Amyloid-β Peptide Aβ1-42 Aggregates Faster and Is More Neurotoxic than Synthetic Aβ1-42
    Finder, Verena H.
    Vodopivec, Ivana
    Nitsch, Roger M.
    Glockshuber, Rudi
    JOURNAL OF MOLECULAR BIOLOGY, 2010, 396 (01) : 9 - 18
  • [36] Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements
    Andreasson, Ulf
    Kuhlmann, Julia
    Pannee, Josef
    Umek, Robert M.
    Stoops, Erik
    Vanderstichele, Hugo
    Matzen, Anja
    Vandijck, Manu
    Dauwe, Martine
    Leinenbach, Andreas
    Rutz, Sandra
    Portelius, Erik
    Zegers, Ingrid
    Zetterberg, Henrik
    Blennow, Kaj
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2018, 56 (12) : 2058 - 2066
  • [37] Stability of Plasma Amyloid-β 1-40, Amyloid-β 1-42, and Total Tau Protein over Repeated Freeze/Thaw Cycles
    Liu, Huei-Chun
    Chiu, Ming-Jang
    Lin, Chin-Hsien
    Yang, Shieh-Yueh
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2020, 10 (01) : 46 - 55
  • [38] The Aβ1-42/Aβ1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1-42 alone
    Delaby, Constance
    Estelles, Teresa
    Zhu, Nuole
    Arranz, Javier
    Barroeta, Isabel
    Carmona-Iragui, Maria
    Illan-Gala, Ignacio
    Santos-Santos, Miguel Angel
    Altuna, Miren
    Sala, Isabel
    Sanchez-Saudinos, M. Belen
    Videla, Laura
    Valldeneu, Silvia
    Subirana, Andrea
    Tondo, Mireia
    Blanco-Vaca, Francisco
    Lehmann, Sylvain
    Belbin, Olivia
    Blesa, Rafael
    Fortea, Juan
    Lleo, Alberto
    Alcolea, Daniel
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [39] Mechanisms of Ultrasonically Induced Fibrillation of Amyloid β1-40 Peptides
    Uesugi, Kentaro
    Ogi, Hirotsugu
    Fukushima, Masahiko
    So, Masatomo
    Yagi, Hisashi
    Goto, Yuji
    Hirao, Masahiko
    JAPANESE JOURNAL OF APPLIED PHYSICS, 2013, 52 (07)
  • [40] Prevention of Amyloid-β Fibril Formation Using Antibodies Against the C-terminal Region of Amyloid-β1-40 and Amyloid-β1-42
    Montanes, Maria
    Casabona, Diego
    Sarasa, Leticia
    Pesini, Pedro
    Sarasa, Manuel
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 34 (01) : 133 - 137